<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04732936</url>
  </required_header>
  <id_info>
    <org_study_id>EPNR-CIP-001</org_study_id>
    <nct_id>NCT04732936</nct_id>
  </id_info>
  <brief_title>Feasibility Study of a Temporary Peripheral Nerve Stimulator</brief_title>
  <official_title>Feasibility Study of a Temporary Peripheral Nerve Stimulator</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Epineuron Technologies Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Epineuron Technologies Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A novel temporary peripheral nerve stimulator will be evaluated for safety, usability, and&#xD;
      preliminary efficacy.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2021</start_date>
  <completion_date type="Anticipated">December 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patient Tolerance to Therapy Questionnaire</measure>
    <time_frame>Immediately after procedure</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Static Two Point Discrimination</measure>
    <time_frame>6 months</time_frame>
    <description>Measurement of spatial determination</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Semmes-Weinstein Monofilament Test</measure>
    <time_frame>6 months</time_frame>
    <description>Measurement of pressure sensitivity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>DASH Questionnaire</measure>
    <time_frame>6 months</time_frame>
    <description>Validated questionnaire for functionality in upper extremity injury</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Safety</measure>
    <time_frame>6 months</time_frame>
    <description>As measured by the cumulative incidence of adverse events.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Device Usability Questionnaire</measure>
    <time_frame>Immediately after procedure</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Nerve Injury</condition>
  <arm_group>
    <arm_group_label>Device Usability</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Device usability and safety will be evaluated.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Preliminary Efficacy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Preliminary treatment efficacy will be evaluated.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Temporary Peripheral Nerve Stimulator</intervention_name>
    <description>Temporary Peripheral Nerve Stimulator to deliver 1-hr of electrical stimulation to injured nerves.</description>
    <arm_group_label>Device Usability</arm_group_label>
    <arm_group_label>Preliminary Efficacy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Are between 18-65 years old&#xD;
&#xD;
          -  Have a Sunderland II-V peripheral nerve injury of the upper extremity&#xD;
&#xD;
          -  Are receiving surgery within 14 days of injury&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Nerve plexus injuries (e.g. brachial plexus)&#xD;
&#xD;
          -  Nerve gap requiring graft/conduit, or extreme joint flexion&#xD;
&#xD;
          -  Polyneuropathies&#xD;
&#xD;
          -  Cognitive impairment and non-English-speaking&#xD;
&#xD;
          -  Uncontrolled diabetes&#xD;
&#xD;
          -  Surgical intervention &gt; 14 days of injury&#xD;
&#xD;
          -  Co-enrollment in another clinical trial&#xD;
&#xD;
          -  Pregnant women&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christopher Coroneos, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>McMaster University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Katelyn Chan</last_name>
    <phone>905-206-0466</phone>
    <email>info@epineurontech.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hamilton General Hospital</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8L2X2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James Bain, MD</last_name>
    </contact>
    <investigator>
      <last_name>James Bain, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>McMaster University Medical Centre</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8N3Z5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James Bain, MD</last_name>
    </contact>
    <investigator>
      <last_name>James Bain, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Joseph's Healthcare Hamilton</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8N4A6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carolyn Levis, MD</last_name>
    </contact>
    <investigator>
      <last_name>Carolyn Levis, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>January 19, 2021</study_first_submitted>
  <study_first_submitted_qc>January 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 1, 2021</study_first_posted>
  <last_update_submitted>August 17, 2021</last_update_submitted>
  <last_update_submitted_qc>August 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

